Hernan Salazar, DO
Internal Medicine · San Antonio, TXNPI 1538220892
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,130 of the $1,839 with a category attached, or 61.4%. Novartis accounts for 63.5% of it on its own, with 1 other manufacturer making up the rest.
Across 30 payments — averaging $61.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Eli Lilly$672
Across 454 payments — averaging $40,787 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$6.7M
- Innocoll Pharmaceuticals Limited$3.2M
- Heron Therapeutics, Inc.$2.1M
- Vertex$2M
- Dexcom, Inc.$1.3M
- Eli Lilly$976K
- plus $2.2M from 13 others
What the payments were for
- Travel & lodging$1,13061%
- Food & beverage$70939%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LEQVIO$666
How this compares
$1,839 in reported general payments places this provider in the 75th percentile of 7,675 internal medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Testosterone Cypionate | 13 | $302 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 15 | $238 |
| Bupropion XlBupropion Hcl | 12 | $142 |
| Levothyroxine Sodium | 17 | $122 |
| Irbesartan | 16 | $118 |
| Metformin Hcl | 12 | $47 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in San Antonio
- Manuel RodriguezSan Antonio$263K
- Matthew CatesSan Antonio$248K
- Fabian Rodas OchoaSan Antonio$68K
- Darius BuzenasSan Antonio$49K
- Spencer BerthelsenSugar Land$891K
- Hameed AliTemple$773K
- Marc TribbleDallas$693K
- Gary SinclairDallas$599K
- Mohammed Al-NajjarEl Paso$586K
- Han SchmidlyDallas$465K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.